HRT Financial’s ProShares UltraShort NASDAQ Biotechnology BIS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-29,990
| Closed | -$928K | – | 1788 |
|
|
2020
Q3 | $928K | Buy |
29,990
+23,154
| +339% | +$716K | 0.03% | 540 |
|
|
2020
Q2 | $219K | Sell |
6,836
-7,075
| -51% | -$227K | 0.01% | 998 |
|
|
2020
Q1 | $787K | Buy |
13,911
+6,424
| +86% | +$363K | 0.05% | 255 |
|
|
2019
Q4 | $401K | Buy |
7,487
+880
| +13% | +$47.1K | 0.02% | 575 |
|
|
2019
Q3 | $529K | Buy |
6,607
+3,515
| +114% | +$281K | 0.03% | 562 |
|
|
2019
Q2 | $210K | Sell |
3,092
-328
| -10% | -$22.3K | 0.01% | 602 |
|
|
2019
Q1 | $228K | Buy |
+3,420
| New | +$228K | 0.04% | 325 |
|
|
2018
Q3 | – | Sell |
-2,837
| Closed | -$220K | – | 366 |
|
|
2018
Q2 | $220K | Buy |
+2,837
| New | +$220K | 0.08% | 176 |
|
|
2017
Q1 | – | Sell |
-2,938
| Closed | -$411K | – | 126 |
|
|
2016
Q4 | $411K | Buy |
+2,938
| New | +$411K | 0.52% | 30 |
|